MAPKAPK5 and hepatocellular carcinoma: Kaplan-Meier survival analysis for the 97 HCC patients showed that HCC patients with high MAPKAPK5-AS1 expression exhibited a notably worse overall survival (p = 0.0002, Fig. 1d).